"
sTRAIL Serum Levels and TRAIL 1595 Genotypes: Associations with Progress and Prognosis of Colorectal Carcinoma"
written by İlhan Yaylım, Nazlı Ezgi Ozkan, Saime Turan, Gurbet Korkmaz, Yemliha Yıldız, Canan Cacina, Bahar Toptaş, Soykan Arıkan,
published by
Journal of Cancer Therapy,
Vol.3 No.6A, 2012
has been cited by the following article(s):
|
[1]
|
Exploring the dynamic role of circulating soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as a diagnostic and prognostic marker; a review
Biochemical and Biophysical Research Communications,
2025
DOI:10.1016/j.bbrc.2025.151415
|
|
|
|
|
[2]
|
Effect of trail C1595T variant and gene expression on the pathogenesis of non-small cell lung cancer
Libyan Journal of Medicine,
2019
DOI:10.1080/19932820.2018.1535746
|
|
|
|
|
[3]
|
Association between Laryngeal Squamous Cell Carcinoma and Polymorphisms in Tumor Necrosis Factor Related Apoptosis Induce Ligand (TRAIL), TRAIL Receptor and sTRAIL Levels
Asian Pacific Journal of Cancer Prevention,
2015
DOI:10.7314/APJCP.2014.15.24.10697
|
|
|
|
|
[4]
|
Restoring TRAIL Mediated Signaling in Ovarian Cancer Cells
Archivum Immunologiae et Therapiae Experimentalis,
2014
DOI:10.1007/s00005-014-0307-9
|
|
|
|